DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Norvir (Ritonavir) - Premature Baby - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Premature Baby (39)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Norvir (Ritonavir) where reactions include premature baby. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 39   Next >>

Possible Norvir side effects in male

Reported by a physician from United States on 2012-08-24

Patient: male, weighing 2.0 kg (4.4 pounds)

Reactions: Hyperbilirubinaemia, Premature Baby, Foetal Exposure During Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Norvir

Other drugs received by patient: Intelence; Epzicom; Prezista; Truvada; Intelence



Possible Norvir side effects in male

Reported by a physician from United States on 2012-08-23

Patient: male, weighing 2.6 kg (5.7 pounds)

Reactions: Foetal Growth Restriction, Premature Baby, Foetal Exposure During Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Other drugs received by patient: Combivir; Zidovudine; Darunavir Ethanolate



Possible Norvir side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14

Patient:

Reactions: Cytogenetic Abnormality, Premature Baby, Foetal Exposure During Pregnancy, Hypoxia, Limb Malformation, Cerebral Haemorrhage, Genetic Polymorphism

Adverse event resulted in: death

Drug(s) suspected as cause:
Truvada
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified



Possible Norvir side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13

Patient: male, weighing 2.7 kg (5.9 pounds)

Reactions: Foetal Growth Restriction, Premature Baby, Foetal Exposure During Pregnancy

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra
    Dosage: unk
    Indication: Maternal Exposure During Pregnancy
    Start date: 2011-04-21
    End date: 2011-04-28

Norvir
    Dosage: 100 mg/day
    Start date: 2011-05-11

Prezista
    Dosage: 800 mg/day
    Indication: Maternal Exposure During Pregnancy
    Start date: 2011-04-28

Zidovudine
    Dosage: 2.0 mg/day
    Indication: Maternal Exposure During Pregnancy
    Start date: 2011-09-15
    End date: 2011-09-15

Norvir
    Dosage: 200 mg/day
    Indication: Maternal Exposure During Pregnancy
    Start date: 2011-04-28
    End date: 2011-05-10

Combivir
    Dosage: unk
    Indication: Maternal Exposure During Pregnancy
    Start date: 2011-04-21
    End date: 2011-09-15



Possible Norvir side effects in male

Reported by a physician from United States on 2012-08-09

Patient: male, weighing 2.6 kg (5.7 pounds)

Reactions: Foetal Growth Restriction, Premature Baby, Foetal Exposure During Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Other drugs received by patient: Darunavir Ethanolate; Zidovudine; Combivir



Possible Norvir side effects in 40 year old female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-08-08

Patient: 40 year old female

Reactions: Premature Rupture of Membranes, Premature Baby, Maternal Exposure During Pregnancy, PRE-Eclampsia

Drug(s) suspected as cause:
Kaletra
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-06-16

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-04
    End date: 2011-04-18

Epivir
    Dosage: 600mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-03-22

Retrovir
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-06-16

Reyataz
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-19
    End date: 2011-06-16

Intelence
    Dosage: 400mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-19
    End date: 2011-06-14

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Start date: 2011-04-04
    End date: 2011-04-18



Possible Norvir side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-08

Patient: male, weighing 2.7 kg (5.9 pounds)

Reactions: Foetal Growth Restriction, Premature Baby, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Zidovudine
    Dosage: 2mgd per day
    Indication: Prophylaxis
    Start date: 2011-09-15
    End date: 2011-09-15

Norvir
    Dosage: 200mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-04-28
    End date: 2011-05-10

Combivir
    Dosage: 2tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-04-21
    End date: 2011-09-15

Prezista
    Dosage: 800mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-04-28

Norvir
    Dosage: 100mgd per day
    Start date: 2011-05-11

Kaletra
    Dosage: 4tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-04-21
    End date: 2011-04-28



Possible Norvir side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-25

Patient:

Reactions: Foetal Growth Restriction, Premature Baby, Foetal Exposure During Pregnancy

Adverse event resulted in: death

Drug(s) suspected as cause:
Zidovudine
    Dosage: 2.0 mg/day
    Indication: Maternal Exposure During Pregnancy
    Start date: 2011-09-15
    End date: 2011-09-15

Norvir
    Dosage: 100 mg/day
    Start date: 2011-05-11
    End date: 2011-12-20

Norvir
    Dosage: 200 mg/day
    Indication: Maternal Exposure During Pregnancy
    Start date: 2011-04-28
    End date: 2011-05-10

Combivir
    Dosage: unk
    Indication: Maternal Exposure During Pregnancy
    Start date: 2011-04-21
    End date: 2011-09-15

Kaletra
    Dosage: unk
    Indication: Maternal Exposure During Pregnancy
    Start date: 2011-04-21
    End date: 2011-04-28

Prezista
    Dosage: 800 mg/day
    Indication: Maternal Exposure During Pregnancy
    Start date: 2011-04-28
    End date: 2011-12-20



Possible Norvir side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-23

Patient: male, weighing 2.7 kg (5.9 pounds)

Reactions: Foetal Growth Restriction, Maternal Drugs Affecting Foetus, Premature Baby

Drug(s) suspected as cause:
Norvir
    Dosage: (200 mg, 11 d),transplacental, (100 mg, 1 d),oral
    Indication: Antiviral Treatment
    Start date: 2011-04-28
    End date: 2011-05-18

Norvir
    Dosage: (200 mg, 11 d),transplacental, (100 mg, 1 d),oral
    Indication: Antiviral Treatment
    Start date: 2011-05-19

Prezista
    Dosage: (800 mg, 1 d),transplacental
    Indication: Antiviral Treatment
    Start date: 2011-04-28

Combivir
    Dosage: transplacental
    Indication: Antiviral Treatment
    Start date: 2011-04-21
    End date: 2011-09-15

Zidovudine
    Dosage: 2 mg, 1 d),transplacental
    Indication: Antiviral Treatment
    Start date: 2011-09-15
    End date: 2011-09-15

Kaletra
    Dosage: transplacental
    Indication: Antiviral Treatment
    Start date: 2011-04-21
    End date: 2011-09-15



Possible Norvir side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-21

Patient: male, weighing 2.7 kg (5.9 pounds)

Reactions: Foetal Growth Restriction, Premature Baby, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Kaletra
    Dosage: 4tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-04-21
    End date: 2011-04-28

Norvir
    Indication: Antiretroviral Therapy
    Start date: 2011-04-28
    End date: 2011-05-10

Combivir
    Dosage: 2tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-04-21
    End date: 2011-09-15

Prezista
    Dosage: 800mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-04-28
    End date: 2011-12-01

Other drugs received by patient: Zidovudine



Possible Norvir side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-11

Patient:

Reactions: Premature Baby, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Norvir



Possible Norvir side effects in

Reported by a consumer/non-health professional from Japan on 2012-05-09

Patient:

Reactions: Premature Baby, Live Birth, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Norvir
    Indication: Antiretroviral Therapy
    Start date: 2009-11-05
    End date: 2010-12-27

Reyataz
    Indication: Antiretroviral Therapy
    Start date: 2009-11-05
    End date: 2010-12-27

Epzicom
    Indication: Antiretroviral Therapy
    Start date: 2009-11-05
    End date: 2010-12-27



Possible Norvir side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-03

Patient:

Reactions: Premature Baby, Congenital Anomaly, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Prezista
    Indication: Maternal Exposure Timing Unspecified



Possible Norvir side effects in 40 year old female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-04-17

Patient: 40 year old female

Reactions: Premature Rupture of Membranes, Premature Baby, Maternal Exposure During Pregnancy, PRE-Eclampsia

Drug(s) suspected as cause:
Epivir
    Dosage: 600mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-03-22

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Start date: 2011-04-04
    End date: 2011-04-18

Kaletra
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-06-16

Intelence
    Dosage: 400mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-19
    End date: 2011-06-14

Reyataz
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-19
    End date: 2011-06-16

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-04
    End date: 2011-04-18

Retrovir
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-06-16



Possible Norvir side effects in 19 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-30

Patient: 19 year old female

Reactions: Premature Baby, Maternal Exposure During Pregnancy, PRE-Eclampsia

Drug(s) suspected as cause:
Combivir
    Dosage: 200mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-08-11
    End date: 2011-11-17

Prezista
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-09-16

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-09-16

Other drugs received by patient: Citalopram Hydrobromide; Vitamin and Mineral Prenatal Supplement W / Folic Acid CAP



Possible Norvir side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-28

Patient: female

Reactions: Premature Baby, Foetal Exposure During Pregnancy, Ankyloglossia Congenital

Drug(s) suspected as cause:
Combivir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Viread
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified



Possible Norvir side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-13

Patient: female

Reactions: Premature Baby, Foetal Exposure During Pregnancy, Ankyloglossia Congenital

Drug(s) suspected as cause:
Reyataz
    Indication: Maternal Exposure Timing Unspecified

Combivir
    Indication: Maternal Exposure Timing Unspecified

Viread
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified



Possible Norvir side effects in 40 year old female

Reported by a physician from Thailand on 2012-03-12

Patient: 40 year old female

Reactions: Premature Rupture of Membranes, Premature Baby, Maternal Exposure During Pregnancy, PRE-Eclampsia

Drug(s) suspected as cause:
Epivir
    Dosage: 600mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-03-22

Reyataz
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-19
    End date: 2011-06-16

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Start date: 2011-04-04
    End date: 2011-04-18

Retrovir
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-06-16

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-04
    End date: 2011-04-18

Intelence
    Dosage: 400mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-19
    End date: 2011-06-14

Kaletra
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-06-16



Possible Norvir side effects in 40 year old female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-03-05

Patient: 40 year old female

Reactions: Premature Rupture of Membranes, Premature Baby, Maternal Exposure During Pregnancy, PRE-Eclampsia

Drug(s) suspected as cause:
Kaletra
    Dosage: 1000mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-06-16

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-03-22

Intelence
    Dosage: 400mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-19
    End date: 2011-06-14

Reyataz
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-03-22
    End date: 2011-06-16

Epivir
    Dosage: 600mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-03-22

Retrovir
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-06-16



Possible Norvir side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-29

Patient:

Reactions: Foetal Growth Restriction, Maternal Drugs Affecting Foetus, Premature Baby, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Prezista
    Dosage: 800 mg daily
    Indication: Maternal Exposure During Pregnancy
    Start date: 2011-04-28

Norvir
    Dosage: 100 mg/day
    Start date: 2011-05-19

Zidovudine
    Dosage: 20 mg/day
    Indication: Maternal Exposure During Pregnancy
    Start date: 2011-09-15
    End date: 2011-09-15

Norvir
    Dosage: 200 mg/day
    Indication: Maternal Exposure Timing Unspecified
    Start date: 2011-04-28
    End date: 2011-05-18

Combivir
    Dosage: unk
    Indication: Maternal Exposure During Pregnancy
    Start date: 2011-04-21
    End date: 2011-09-15

Kaletra
    Dosage: unk
    Indication: Maternal Exposure During Pregnancy
    Start date: 2011-04-21
    End date: 2011-04-28



Possible Norvir side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-23

Patient: male, weighing 0.4 kg (0.9 pounds)

Reactions: Foetal Growth Restriction, Maternal Drugs Affecting Foetus, Premature Baby

Drug(s) suspected as cause:
Zidovudine
    Dosage: transplacental
    Indication: Antiviral Treatment
    Start date: 2011-09-15
    End date: 2011-09-15

Prezista
    Dosage: (800 mg, 1 d), transplacental
    Indication: Antiviral Treatment
    Start date: 2011-04-28

Combivir
    Dosage: transplacental
    Indication: Antiviral Treatment
    Start date: 2011-04-21
    End date: 2011-09-15

Norvir
    Dosage: (200 mg, 1 d), transplacental
    Indication: Antiviral Treatment
    Start date: 2011-04-28
    End date: 2011-05-18

Kaletra
    Dosage: transplacental
    Indication: Antiviral Treatment
    Start date: 2011-04-21
    End date: 2011-04-28



Possible Norvir side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-23

Patient:

Reactions: Umbilical Cord Vascular Disorder, Premature Baby, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Truvada
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Isentress
    Indication: Maternal Exposure Timing Unspecified

Prezista
    Indication: Maternal Exposure Timing Unspecified

Viramune
    Indication: Maternal Exposure Timing Unspecified



Possible Norvir side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-23

Patient: female

Reactions: Premature Baby, Foetal Exposure During Pregnancy, Ankyloglossia Congenital

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Viread
    Indication: Maternal Exposure Timing Unspecified

Combivir
    Indication: Maternal Exposure Timing Unspecified



Possible Norvir side effects in male

Reported by a physician on 2012-02-20

Patient: male

Reactions: Neonatal Respiratory Failure, Foetal Chromosome Abnormality, Premature Baby, Intraventricular Haemorrhage Neonatal, Foetal Exposure During Pregnancy, Hypoxia, Limb Malformation

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz
    Indication: Maternal Exposure Timing Unspecified

Zopiclone
    Indication: Maternal Exposure Timing Unspecified

Methadon HCL TAB
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Norvir side effects in male

Reported by a physician on 2012-02-16

Patient: male

Reactions: Neonatal Respiratory Failure, Foetal Chromosome Abnormality, Premature Baby, Intraventricular Haemorrhage Neonatal, Foetal Exposure During Pregnancy, Hypoxia, Limb Malformation

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Methadon HCL TAB
    Indication: Maternal Exposure Timing Unspecified

Zopiclone
    Indication: Maternal Exposure Timing Unspecified



Possible Norvir side effects in

Reported by a physician from Japan on 2012-02-16

Patient:

Reactions: Premature Baby

Drug(s) suspected as cause:
Reyataz
    Dosage: started on (05nov09-02dec09,03dec09-27dec10).
    Indication: HIV Infection
    Start date: 2009-11-05
    End date: 2010-12-27

Norvir
    Indication: HIV Infection
    Start date: 2009-11-05
    End date: 2009-12-02

Epzicom
    Indication: HIV Infection
    Start date: 2009-11-05
    End date: 2010-12-27



Possible Norvir side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-08

Patient: male

Reactions: Premature Baby, Foetal Exposure During Pregnancy, Congenital Choroid Plexus Cyst

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Epzicom
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified



Possible Norvir side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-19

Patient: female, weighing 2.4 kg (5.3 pounds)

Reactions: Foetal Growth Restriction, Ultrasound Scan Abnormal, Premature Baby, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Norvir
    Dosage: 200mg per day
    Indication: Antiviral Treatment
    Start date: 2010-02-18

Combivir
    Dosage: 200mg per day
    Indication: Antiviral Treatment
    Start date: 2010-01-12
    End date: 2010-06-03

Prezista
    Dosage: 1200mg per day
    Indication: Antiviral Treatment
    Start date: 2010-02-18

Other drugs received by patient: Retrovir



Possible Norvir side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-16

Patient:

Reactions: Cytogenetic Abnormality, Premature Baby, Foetal Exposure During Pregnancy, Hypoxia, Limb Malformation, Cerebral Haemorrhage, Genetic Polymorphism

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified



Possible Norvir side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-13

Patient:

Reactions: Cytogenetic Abnormality, Premature Baby, Foetal Exposure During Pregnancy, Hypoxia, Limb Malformation, Cerebral Haemorrhage, Genetic Polymorphism

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017